JOURNAL OF PHARMACEUTICAL ADVANCED RESEARCH

    (An International Open Access Peer Review Online Monthly Journal)  e - ISSN: 2581-6160 (Online)

  
                                

Current Issue Publication Highlight

JPAR EDITORIAL POLICY

Dear scientists, researchers, readers and followers welcome to Journal of Pharmaceutical Advanced Research.

The publication of an article in a peer reviewed journal is an mandatory model for Journal of Pharmaceutical Advanced Research. It is important to give concern and agree upon standards of desire ethical behavior for all associated parties in the process of publishing: the author, the journal editorial and the peer reviewer. Any paper or manuscript or substantial parts of it, submitted to the Journal of Pharmaceutical Advanced Research must not be under consideration by any other journal for publication. In general, the manuscript should not have already been published in any journal. Authors are required to ensure and confirm that no material submitted as part of a manuscript infringes existing copyrights.

Role of Editorial Board Members:

The editor of Journal of Pharmaceutical Advanced Research should give unintentionally, unbiased ethical consideration to all papers or manuscripts offered for publication, judging each on its significance, merits without regard to race, gender, religious belief, ethnic origin, citizenship, or political philosophy of the author(s).

The editor of Journal of Pharmaceutical Advanced Research has complete responsibility and authority to accept a submitted paper for publication or to reject it. The editor may confer with reviewers for an evaluation to use in making this decision.

The editor and the editorial staff of Journal of Pharmaceutical Advanced Research should not disclose any information about a manuscript under consideration to anyone other than reviewers and potential reviewers. The editor should respect the intellectual independence of authors. Editorial responsibility and authority for any manuscript authored by the editor and submitted to the Journal of Pharmaceutical Advanced Research should be delegated to some other qualified person. The editor should avoid situations of real or perceived conflicts of interest. If the editor chooses to participate in an ongoing scientific debate within his journal, the editor should arrange for some other qualified person to take editorial responsibility.

The editor of Journal of Pharmaceutical Advanced Research should avoid situations of real or perceived conflicts of interest. Such conflicts include, but are not limited to, handling papers from present and former students, from colleagues with whom the editor has recently collaborated, and from those in the same institution.

Unpublished information, arguments, or interpretations disclosed in a submitted manuscript should not be used in an editor's own research except with the consent of the author. Author’s responsibility:

Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted. An author should not in general publish articles describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication.

The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication. Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. The author intends not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object.

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

The copyright for any material created by the author is reserved. Any duplication or use of objects such as images, diagrams, sounds or texts in other electronic or printed publications is not permitted without the author's agreement.

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

JPAR PEER REVIEW PROCESS:

Peer review is intended to improve the accuracy, clarity, and completeness of published manuscripts and to help editors decide which manuscripts to publish. Peer review does not guarantee manuscript quality and does not reliably detect scientific misconduct.

Peer reviewers should be experts in the manuscript’s content area, research methods, or both; a critique of writing style alone is not sufficient.

Peer reviewers should be selected based on their expertise and ability to provide high quality, constructive, and fair reviews. For research manuscripts, editors may, in addition, seek the opinion of a statistical reviewer.

Peer reviewers advise editors on how a manuscript might be improved and on its priority for publication in that journal. Editors decide whether and under which conditions manuscripts are accepted for publication, assisted by reviewers’ advice. Peer reviewers are sometimes paid for their efforts but usually provide their opinions free of charge, as a service to their profession.

Editors should require all peer reviewers to disclose any conflicts of interest, financial or otherwise, related to a particular manuscript and should take this information into account when deciding how to use their review. Generally speaking, people with a direct financial interest in the results of the manuscripts should not be reviewers.

To be considered peer reviewed, a journal should have obtained external reviews for the majority of manuscripts it publishes, including all original research and review articles. Some editors request peer review for other kinds of articles, such as opinion pieces (commentaries/editorials) and correspondence. To have been peer reviewed, a manuscript should have been reviewed by at least one external reviewer; it is typical to have two reviewers and sometimes more opinions are sought.

Editors of peer-reviewed journals need not send all submitted manuscripts out for review. Manuscripts that seem unlikely to be published in that journal may be returned to authors without external review, to allow authors to submit the manuscript to another journal without delay and to make efficient use of reviewers’ and editors’ time.

Editors should state their journal’s peer review policies, including which kinds of article are peer reviewed and by how many reviewers, in the instructions for authors.

Editors should also periodically publish statistics describing their journal’s review process, such as number of manuscripts submitted, acceptance rate, and average times from manuscript submission to rejection letter to authors and, for accepted manuscripts, time to publication. All published articles in Journal of Pharmaceutical Advanced Research are peer reviewed and all manuscripts submitted follows the procedure outlined below.

Initial Manuscript Evaluation: All manuscripts submitted for publication in Journal are firstly evaluated by the Editorial Board Members. The editors employ double blind reviewing, where both the referee and author remain anonymous throughout the process.

Referee Evaluation: After initial evaluation, the manuscripts are sent to a minimum of two external referees for peer-review. If necessary, the number of referees can be increased by editors. The referees are chosen from referee board according to their expertise. Referees are asked to evaluate the manuscript’s originality, methodology, contribution to the literature, presentation of results and support for the conclusions, and appropriate referencing of previous relevant studies. Referees might accept the manuscript, reject the manuscript or might require a revision for style and/or content.

Revision requirement: When a revision is required by the referee or referees, the author(s) are to consider the suggestions offered by the referees, and they should be sent back the revised version of manuscript in one month. Revised manuscripts returned after one month will be considered as a new submissions and peer review process is started from the beginning. Referees may request more than one revision of a manuscript.

Editorial decisions over manuscript:

Accepted as it is Accepted after minor revision
Accepted after major revision
Rejected

Minor revision: If minor revision is required, authors should return a revised version as soon as possible within one week. If major revision is required, authors should return a revised version within two to three weeks.

Final Evaluation: After favorable opinions of referees, editorial board is made the final evaluation. The articles accepted for publication by editorial board are placed in an issue sequence.

Time of Peer Review Process: The peer review process that has long time is an important problem. Naturally, the author(s) wish to take an answer about their submissions. The journal aims to complete the all peer review process within 2-3 weeks after submission. This time, however, may vary depending on the amount of revision work that needs to be completed before the manuscript is acceptable.

Role of Reviewers:

Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Any papers received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself/herself from the review process.

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation.

A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.


2017- 2018 Journal of pharmaceutical advanceed research      Contact Us :+91-9938860284   Email: jpar.editor@jparonline.com, submitjpar@jparonline.com